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Introduction {#sec1}
============

Under the proper culture conditions, embryonic stem cells (ESCs) can self-renew indefinitely or differentiate into cell types of all germ layers (pluripotency). The maintenance of the pluripotent state is controlled by a network of transcription factors (TFs; [@bib31]). The expression levels of several of those TFs are heterogeneous in individual pluripotent ESCs in traditionally used serum plus leukemia inhibitory factor (LIF) culture conditions (SerumLIF; [@bib9], [@bib43], [@bib44]). Nanog, an extensively studied key pluripotency regulator ([@bib8], [@bib26], [@bib43]), has been shown to fluctuate between low and high expression in pluripotent ESCs ([@bib1], [@bib9], [@bib17], [@bib23], [@bib38]).

Dual inhibition of the signaling kinases GSK3 and MEK (2i) together with LIF promotes self-renewal of mouse ESCs in a state more similar to the pluripotent preimplantation epiblast ([@bib5], [@bib48]). In 2i conditions, ESC cultures are more homogeneous with a more uniform and high Nanog expression ([@bib1], [@bib16], [@bib38], [@bib45]). It is usually assumed that this shift in the Nanog distribution occurs because 2i upregulates Nanog expression in individual ESCs. Some publications suggest that GSK3 and MEK inhibitors increase Nanog transcription, protein synthesis, or stability ([@bib21], [@bib24], [@bib27], [@bib30], [@bib33], [@bib38]), and induce Nanog expression during the reprogramming to naive pluripotency ([@bib36], [@bib41]).

However, these conclusions are based on Nanog quantifications of population averages and/or long after the start of 2i treatment. A reduction in Nanog decreases after 2i treatment was shown in single cells, but only in a qualitative way, and Nanog-dependent cell deaths were not quantified ([@bib7]). A selective effect of 2i cannot, therefore, be ruled out ([@bib1], [@bib5], [@bib14], [@bib32]). In this situation, 2i treatment would lead to the death or reduced proliferation specifically of Nanog low-expressing ESCs, thus enriching cultures for a uniform Nanog high-expressing population. 2i treatment would thus not have an effect on Nanog expression at the single-cell level but would differentially influence survival and/or proliferation speed in ESC subsets. In line with a potential selective effect of 2i, epiblast stem cells, which are in an alternative pluripotent state, as well as somatic cells at early stages of reprogramming, die or differentiate in 2i conditions ([@bib19], [@bib36]). A potential selective 2i effect has also been assumed to assess the exit from the ESC state *in vitro* ([@bib4]).

Given the widespread use of 2i treatment for research of the molecular control of pluripotency, it is therefore important to quantitatively clarify whether 2i effects on ESCs are in fact inductive or selective, or whether both effects simultaneously contribute to the observed homogenization of Nanog expression in ESC populations. Here, we performed continuous time-lapse imaging of Nanog reporter mouse ESC lines and quantified the dynamics of 2i-induced cell death events, cell proliferation rates, and Nanog expression ([@bib13], [@bib39]).

Results {#sec2}
=======

Inductive and Selective 2i Effects Can Be Distinguished by Continuous Single-Cell Quantification {#sec2.1}
------------------------------------------------------------------------------------------------

We confirmed that dual GSK3/MEK inhibition reduces the number of Nanog low-expressing cells using two different reporter ESC lines: a Nanog:GFP cell line (NG4) reporting transcription from a transgenic *Nanog* promoter ([@bib34]), and a Nanog^KATUSHKA^ knockin cell line reporting endogenous NANOG protein levels from one *Nanog* allele ([@bib16]; [Figure 1](#fig1){ref-type="fig"}A). We aimed to distinguish whether 2i either induces or maintains high Nanog levels, or rather selects for Nanog high cells ([Figure 1](#fig1){ref-type="fig"}B). Hence, we applied continuous time-lapse imaging to track individual cells and quantified their Nanog expression after plating in SerumLIF or SerumLIF+2i. We confirmed that our experimental conditions, like the use of E-cadherin for plate coating, were largely neutral to the cells ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C). To obtain a representative dataset of many different clonal colonies, we tracked one random sister cell after each cell division, resulting in one branch per tree (a total of 1,383 independent branches; see [Figure S1](#mmc1){ref-type="supplementary-material"}D for counts of individual experiments). To check for a potential selective effect of 2i, we measured the Nanog level in each tracked cell at the start of the movie (d0) and analyzed whether it or its progeny survived for 2 days (d2) when about 50% of the cells were in generation 3. To test for an inductive effect, we calculated the fold change of Nanog expression at d2 over d0 in each surviving branch. To distinguish between cell deaths induced by 2i and not by cell splitting, we quantified early deaths before the first cell division (in generation 0) and later deaths separately ([Figure 1](#fig1){ref-type="fig"}C; e.g., cells 12 and 13 in [Video S1](#mmc2){ref-type="supplementary-material"}).Figure 1Analysis of 2i Effects on Nanog Expression by Continuous Single-Cell Quantification(A) Effects of 2i treatment on Nanog expression in ESC populations. Flow-cytometry analysis at the experiment start (d0) and after 2 days (d2) in SerumLIF with or without 2i. Wild-type ESCs were used as control for cell autofluorescence. One of three representative experiments is shown.(B) Question of the study: at the single-cell level, the Nanog distribution change after 2i treatment can be explained either by induction and maintenance of high Nanog expression or by a negative selection against low Nanog-expressing cells.(C) Experimental setup. Four representative trees are shown for the three groups we distinguish. Tracked cells are indicated by black circles (one random branch per tree, 1,383 branches). Pink crosses indicate cell death. Green bars indicate each of five time points when Nanog expression fold changes were calculated (d2 over d0) and cell survival was determined (d2). Question marks indicate cells that were not tracked. The first cell of a tree is defined as generation 0.(D) Quantification of Nanog expression with image analysis in d0 cells and surviving d2 cells reproduced the Nanog distribution change in 2i between d2 and d0 (Nanog:GFP line: 343 branches in SerumLIF and 361 in SerumLIF+2i; Nanog^KATUSHKA^ line: 331 branches in SerumLIF and 348 in SerumLIF+2i; data were pooled from three independent experiments). The selection of cells at d0 was intentionally biased toward low-expressing cells to obtain higher numbers of Nanog low ESCs for robust statistical analysis. See also [Figure S1](#mmc1){ref-type="supplementary-material"}F. Low/mid/high compartments, indicated by dashed lines, were defined by arbitrary thresholds and used the same way in [Figures 3](#fig3){ref-type="fig"}B, [S3](#mmc1){ref-type="supplementary-material"}A, and [4](#fig4){ref-type="fig"}A.In (A) and (D), the smooth density estimate of each distribution was scaled to a maximum value of 1 (same for [Figures S1](#mmc1){ref-type="supplementary-material"}B, S1C, S1F, [2](#fig2){ref-type="fig"}D, [2](#fig2){ref-type="fig"}F, and [S2](#mmc1){ref-type="supplementary-material"}A). See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

The reduction of Nanog low cells after 2i addition within 2 days was also observed by our imaging approach in both serum-containing ([Figure 1](#fig1){ref-type="fig"}D) and serum-free ([Figure S1](#mmc1){ref-type="supplementary-material"}F) basal medium. Of note, this occurred independently of potential selective proliferation effects: since we only analyzed one branch per tree, each cell at d0 contributed exactly one cell to the measured d2 distribution when the branch was surviving. In addition, we compared proliferation (determined by the cell generation of a branch at d2) with Nanog expression at d0 for each surviving branch, and found that they were weakly positively correlated. However, this was independent of 2i treatment (Spearman correlation for Nanog:GFP = 0.36 ± 0.13/0.45 ± 0.13, and for Nanog^KATUSHKA^ = 0.27 ± 0.06/0.29 ± 0.07, without/with 2i, respectively; mean ± SD, n = 3 independent experiments). Thus, 2i treatment does not influence the proliferation differences between Nanog low and high cells and hence, a selective proliferation effect cannot explain the observed changes in Nanog expression distributions after 2i treatment.

2i Selects for Nanog High-Expressing ESCs {#sec2.2}
-----------------------------------------

We next analyzed whether 2i selectively induces cell death in Nanog low-expressing cells. The cell population dying immediately before the first cell division was strongly enriched for Nanog low cells ([Figure S2](#mmc1){ref-type="supplementary-material"}A), independently of 2i treatment. These Nanog low-specific cell deaths are constantly introduced, likely by cell splitting of ESC cultures, irrespective of 2i. In contrast, ESCs that would die in later generations were enriched for Nanog low cells in SerumLIF+2i compared with SerumLIF ([Figure S2](#mmc1){ref-type="supplementary-material"}A). For statistical analysis, we divided the Nanog distribution into low and mid/high cells based on this differential enrichment. Nanog low cells had significantly higher death rates than mid/high cells in generation 0, regardless of 2i ([Figure 2](#fig2){ref-type="fig"}A). This difference was also observed with conventional gelatin plate coating or in serum-free 2i + LIF medium ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). In later generations, cell death rates of Nanog low cells were significantly higher than those of mid/high cells only after 2i addition ([Figure 2](#fig2){ref-type="fig"}A). This 2i-specific selective effect also occurred in serum-free 2i + LIF medium ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Furthermore, it did not depend on the threshold we had chosen. It was also seen when dividing Nanog levels into seven equally spaced bins. Indeed, Nanog levels and cell death rates are negatively correlated in later generations in SerumLIF+2i, with no or a slightly positive correlation in SerumLIF ([Figure 2](#fig2){ref-type="fig"}B). When analyzing the time until death, we found a late-dying population generated from Nanog low ESCs (between ∼25 and 48 hr), which was only present in SerumLIF+2i ([Figure 2](#fig2){ref-type="fig"}C). This further validates a 2i-specific selective effect against Nanog low ESCs. Of note, cell death rates were higher for Nanog^KATUSHKA^ than for Nanog:GFP ESCs, indicating additional unknown factors influencing cell survival. Importantly, however, 2i led to increased survival of high cells compared with low cells in both reporter lines, and thus, Nanog high cells were overall enriched by a selective effect of 2i.Figure 2Addition of 2i Selects for Nanog High-Expressing Cells(A) Nanog low cells have higher death rates than mid/high cells before the first cell division irrespective of 2i treatment. In addition, only 2i induces death of Nanog low cells in later generations (Cochran-Mantel-Haenszel chi-squared test; means \[n = 3 experiments\] are shown as bars). n.s., not significant. See also [Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C and [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.(B) Death rates in generation 0 (2i independent) and 2i-specific death rates in later generations gradually decrease with increasing Nanog levels. Cells at d0 were binned for Nanog levels and fractions of dying branches were determined for each bin. No data points for bins without branches are shown. See also [Figure S2](#mmc1){ref-type="supplementary-material"}D for absolute branch counts.(C) 2D density plots of dying cells reveal a subpopulation of Nanog low cells dying after ∼25--48 hr only present in SerumLIF+2i (magenta boxes).(D) Quantitative immunostaining shows that the *Nanog*^*−/−*^ rescue cell line, where Nanog is expressed from a constitutive promoter in a *Nanog*^*−/−*^ background, expresses NANOG protein at endogenous levels. One representative experiment is shown (n \> 7,900 cells per condition, pooled from two technical replicates).(E) Proliferation of the *Nanog*^*−/−*^ cell population collapses 2 days after 2i addition but is rescued by constitutive Nanog expression. Means are shown as lines and individual experiments as points. Nanog^WT^ denotes Nanog:GFP reporter cells that have both endogenous wild-type *Nanog* alleles. *Nanog*^*−/−*^ cells were only cultured for 8 days in 2i due to scarcity of cells. See also [Figure S2](#mmc1){ref-type="supplementary-material"}E.(F) The selective effect of 2i cannot fully explain the measured Nanog distribution change in SerumLIF+2i. The Nanog distribution at d0 of branches surviving for 2 days in SerumLIF+2i (green; from [Figure S2](#mmc1){ref-type="supplementary-material"}A) is compared with the measured SerumLIF+2i distributions at d0 (black) and d2 (blue; from [Figure 1](#fig1){ref-type="fig"}D). See text for further explanations and [Figure S2](#mmc1){ref-type="supplementary-material"}A for d0 Nanog distributions of the corresponding dying populations.In (B), (C), and (F), data were pooled from three independent experiments. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

To distinguish whether Nanog expression is just a predictor for cell death probability or whether NANOG itself is important for cell viability in 2i conditions, we genetically controlled Nanog levels. We compared Nanog:GFP cells that contain both wild-type *Nanog* alleles (here referred to as *Nanog*^*WT*^) with *Nanog*^*−/−*^ cells, where both *Nanog* alleles are knocked out ([@bib9]), and *Nanog*^*−/−*^ rescue cells, where a transgene constitutively expressing Nanog is stably integrated into *Nanog*^*−/−*^ cells. We confirmed by quantitative immunostaining that NANOG was absent in *Nanog*^*−/−*^ cells and that the *Nanog*^*−/−*^ rescue cell line expressed NANOG at wild-type levels ([Figure 2](#fig2){ref-type="fig"}D). We then measured the proliferation of the cell populations with or without 2i every 2 days. While *Nanog*^*WT*^ cell proliferation was normal independent of 2i, we observed a drastic reduction of *Nanog*^*−/−*^ cell counts after the first cell splitting in SerumLIF+2i, but not in SerumLIF. *Nanog*^*−/−*^ cell counts continuously decreased in 2i, but *Nanog*^*−/−*^ rescue cells proliferated similarly to wild-type cells in both conditions. This demonstrates that NANOG protein is important for cell viability in 2i ([Figure 2](#fig2){ref-type="fig"}E). We also observed a strong reduction of *Nanog*^*−/−*^ cell counts in serum-free 2i + LIF medium, but the population did not fully collapse and morphologically normal colonies were predominant after 10 days, indicating that NANOG protein is important but can be dispensable under certain conditions even in the presence of 2i ([Figure S2](#mmc1){ref-type="supplementary-material"}E).

We then addressed the question of whether the observed cell death-based selective effect is sufficient to explain the Nanog distribution change after 2i addition in our time-lapse data. We therefore determined the d0 Nanog distribution of surviving branches in SerumLIF+2i. This distribution is equivalent to a theoretical d2 Nanog distribution generated exclusively by selective cell death effects and without changes in Nanog expression of individual cells ([Figure 2](#fig2){ref-type="fig"}F). We then compared the SerumLIF+2i d0 distribution of surviving branches with the measured SerumLIF+2i d2 distribution (which includes Nanog expression dynamics in single cells) and found that Nanog low and mid cells were much more decreased in the latter ([Figure 2](#fig2){ref-type="fig"}F). Therefore, a selective cell death effect of 2i against Nanog low-expressing ESCs exists, but is not sufficient to explain the enrichment of Nanog high ESCs in 2i-treated populations.

2i Also Induces and Maintains High Nanog Expression in Single ESCs {#sec2.3}
------------------------------------------------------------------

Thus, we tested how dual GSK3/MEK inhibition changes the Nanog expression dynamics in individual cells by continuous single-cell quantification ([Figure 3](#fig3){ref-type="fig"}A). We found many trees with strongly increased Nanog expression within 2 days in 2i ([Figure 3](#fig3){ref-type="fig"}A; [Videos S2](#mmc3){ref-type="supplementary-material"} and [S3](#mmc4){ref-type="supplementary-material"}). To better detect differences of Nanog dynamics within the mid/high compartment, we binned ESCs into Nanog low, mid, and high expression at d0 ([Figures 1](#fig1){ref-type="fig"}D, [S1](#mmc1){ref-type="supplementary-material"}F, [3](#fig3){ref-type="fig"}B, and [4](#fig4){ref-type="fig"}A). Nanog expression was significantly increased after 2i addition in single-cell branches, regardless of whether we pooled all cells or analyzed the low, mid, and high compartments individually ([Figure 3](#fig3){ref-type="fig"}B). Nanog was also significantly upregulated in low and mid cells after switching to serum-free 2i + LIF medium ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Importantly, many observed Nanog changes were higher than 2-fold and therefore could not be explained by cell-cycle effects alone. Addition of 2i to SerumLIF induced high Nanog expression in low and mid cells, and maintained this state in already high Nanog-expressing cells. Thus, most surviving cells were Nanog high after 2 days, except a minor fraction that did not upregulate, or even downregulate Nanog in 2i ([Figure 3](#fig3){ref-type="fig"}C). Those cells also showed a reduced cell proliferation speed and large sizes at d2 ([Figure 3](#fig3){ref-type="fig"}D). In contrast, the major Nanog low cell population present in SerumLIF, with cell areas (\<1,000 μm^2^) and proliferation rates (at least in generation 2 at d2) similar to those in Nanog high cells, was strongly reduced after 2i addition (65%/21% of Nanog low cells or 22%/3% of all cells at d2, without/with 2i; pooled from three independent Nanog:GFP experiments), indicating that the remaining low cells in SerumLIF+2i are distinct from most of the Nanog low cells in SerumLIF. Additionally, we found that Nanog:GFP low cells with a large cell area often expressed only very low levels of the pluripotency markers POU5F1 (previously known as OCT4), SOX2, and KLF4, and endogenous NANOG protein. In contrast, morphologically normal Nanog low ESCs in SerumLIF conditions, which also had low NANOG protein, typically expressed high POU5F1 and SOX2 levels ([Figure S3](#mmc1){ref-type="supplementary-material"}B). We conclude that 2i generally increases Nanog expression in single cells but some, especially very low Nanog-expressing cells, do not respond in the same way.Figure 32i Treatment Induces Nanog Upregulation and Prevents Its Downregulation in Single Mouse ESCs(A) Representative example trees of low Nanog^KATUSHKA^-expressing cells in SerumLIF or SerumLIF+2i. Single branches are highlighted in black. Green boxes indicate the time points at d0 and d2 that were used for Nanog quantification in (B) to (D). See also [Figure S4](#mmc1){ref-type="supplementary-material"}A.(B) Log~10~ fold changes of Nanog expression in single-cell branches show that 2i upregulates Nanog expression and prevents its downregulation. Surviving cells were either all pooled or binned by Nanog levels at d0. The red dashed line indicates Nanog maintenance and black dashed lines indicate 2-fold changes. p values were calculated using the Wilcoxon rank-sum test. See also [Figure S3](#mmc1){ref-type="supplementary-material"}A.(C) Induction and maintenance of a high Nanog state after 2i addition in most cell branches. A minor fraction characterized by strongly reduced proliferation does not enter a Nanog high state after 2i addition.(D) After 2 days in SerumLIF+2i two cell populations exist, which are distinct in Nanog levels, cell area, and cell proliferation, but a Nanog low population with small cell area and high cell proliferation present in SerumLIF is nearly absent.In (B) to (D), data were pooled from three independent experiments. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.Figure 4Nanog Upregulation Dynamics in SerumLIF+2i Depends on Nanog Levels Rather than Cell Survival(A) Cells with distinct Nanog levels show different Nanog upregulation kinetics in SerumLIF+2i. Original data points and smoothed curves of mean Nanog levels of low, mid, and high compartments (grouped at d0) are shown over time.(B) Strategy to analyze Nanog upregulation kinetics before cell death. An example branch is shown for visualization. The maximum Nanog level (max), its fold change compared with d0, and the associated time point as well as the first time point where a fold change was bigger than 2 (\>2-fold) were determined (yellow boxes). Those extracted parameters were used for (C) and (D) as well as [Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C. See also [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.(C) A large fraction of Nanog low cells upregulates Nanog more than 2-fold (red dashed line) before cell death in SerumLIF+2i (Nanog:GFP \[61%, n = 28 branches\] and Nanog^KATUSHKA^ \[51%, n = 37 branches\]). Cells that died in generation 0 were excluded from analysis.(D) Nanog is upregulated on average in low cells in SerumLIF+2i independent of survival. The dataset was filtered on dying branches that upregulated Nanog \>2-fold until death and surviving branches that upregulated Nanog \>2-fold from d0 to d2. Cells that died in generation 0 were excluded from analysis. Time points containing less than 9 branches are not shown.(E) Summary of cell fates of low (l), mid (m), and high (h) Nanog-expressing cells in SerumLIF −/+ 2i. "Downregulation" and "Upregulation" include greater than 2-fold Nanog decreases or increases, respectively. All dying cells are contained in the two "Death" groups and all surviving cells in the other groups. Means ± SEM are shown (n = 3).In (A), (C), and (D), data were pooled from three independent experiments. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Kinetics and Concurrence of 2i Effects {#sec2.4}
--------------------------------------

We next checked the temporal order of selective and inductive 2i effects. We analyzed the mean Nanog expression dynamics within different Nanog expression compartments. We found that the Nanog:GFP reporter, which measures transcriptional activity, showed a consistent and rapid GFP upregulation after 2i addition compared with the control. This was apparent immediately in Nanog low cells and after around 3--6 hr in the other compartments. In contrast, the dynamics of the fusion-protein reporter Nanog^KATUSHKA^ varied strongly between compartments ([Figure 4](#fig4){ref-type="fig"}A). Here, Nanog levels started to increase in low cells also immediately after 2i addition, but only after about 1 day in mid cells. In Nanog high cells, levels even dropped initially in a 2i-independent fashion and started to increase again after about 1.5 days compared with SerumLIF.

Of note, this subpopulation analysis is able to disentangle the typical dynamics of larger groups well, but individual cells can still deviate substantially from the averages shown. For example, we found very variable Nanog onset times, maximum Nanog levels, and occurrences of fluctuations within single Nanog low branches in SerumLIF+2i ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Fluctuations were more prominent for Nanog^KATUSHKA^ than Nanog:GFP, which might be a result of transcriptional bursting ([@bib30]) or post-transcriptional Nanog regulation.

We then checked whether the inductive 2i effect also occurs in branches that eventually die. Our focus was on Nanog low cells that died in later generations after the first cell division in SerumLIF+2i. We first established a method that allowed us to detect when and how much Nanog was upregulated in those branches before cell death ([Figure 4](#fig4){ref-type="fig"}B). We found that in over 50% of those branches Nanog had increased more than 2-fold any time before death ([Figure 4](#fig4){ref-type="fig"}C). This threshold was reached for Nanog:GFP after around 10 hr, similarly to a comparable subset of surviving branches ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Also, the average Nanog:GFP upregulation dynamics were the same as in the surviving branches ([Figure 4](#fig4){ref-type="fig"}D). Nanog^KATUSHKA^ upregulation appeared slightly later and weaker in the dying branches, but qualitatively comparable with the surviving ones. We also observed that dying branches that survived longer upregulated Nanog more and that upregulation reached its maximum shortly before cell death ([Figure S4](#mmc1){ref-type="supplementary-material"}C).

We have described above that the selective 2i effect predominantly occurs after the first cell division ([Figure 2](#fig2){ref-type="fig"}A), starting after around 25 hr ([Figure 2](#fig2){ref-type="fig"}C), and thus later than the inductive effect, which already becomes detectable after a few hours ([Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}B). Together, those preliminary data show that the inductive 2i effect also occurs in about half of the dying Nanog low branches. Nevertheless it remains uncertain whether those are exactly the branches where 2i was the reason for death. This complexity is further illustrated by two examples, where Nanog induction, cell death, or ceased proliferation co-occur either in the same cells or separately in different cells within one colony ([Videos S1](#mmc2){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}). We provide a quantitative overview of the main findings from our time-lapse data in [Figure 4](#fig4){ref-type="fig"}E.

Discussion {#sec3}
==========

We quantitatively assessed both the selective and inductive effects of 2i treatment on changing Nanog expression in ESC populations at the single-cell level. Both selective and inductive effects exist in heterogeneous ESC cultures. The high resolution of our continuous and quantitative single-cell data allowed us to distinguish a 2i-specific selective effect against Nanog low cells from the generally reduced survival and proliferation potential of Nanog low cells ([@bib1], [@bib9], [@bib23]). A previous time-lapse-based study failed to detect this selective effect because cell death events were neither observed over several cell generations nor correlated with Nanog expression. In addition, Nanog induction in Nanog low cells was not analyzed possibly because the reporter used did not faithfully report Nanog protein expression in low cells ([@bib7]).

It has been previously mentioned that *Nanog*^*−/−*^ ESCs expand more efficiently in 2i + LIF than in SerumLIF medium, but without supporting data ([@bib37]). In contrast, we observed that morphologically normal *Nanog*^*−/−*^ colonies persisted in serum-free 2i + LIF medium for at least 10 days, but a switch to 2i caused severe viability defects, and in combination with serum even a continued collapse of the culture. We demonstrate that forced long-term NANOG expression safeguards cell survival in 2i conditions, but there was no indication that 2i induced Nanog upregulation would protect Nanog low cells from the selective effect. A previous study showed that 2i enhances Nanog transcription in *Nanog*^*−/−*^ cells but also increases their propensity to differentiate ([@bib28]). A different *Nanog*^*−/−*^ ESC line did not acquire a naive-like phenotype upon transfer to 2i + LIF media, but cell viability was not analyzed in detail ([@bib2]). In combination with our data, this suggests that 2i has two independent effects in Nanog low or *Nanog*^*−/−*^ cells: the induction of Nanog expression and the control of their cell fate.

This complexity of 2i effects is further increased by the heterogeneity of Nanog low cells in SerumLIF cultures. We have previously shown that the Nanog protein level alone is a poor marker for the functional state of ESCs ([@bib17]). Only a fraction of Nanog low cells can revert to the high state, and only those fluctuating cells, and not those in a persistent Nanog low state, are functionally similar to Nanog high cells. The Nanog low population further contains cells that either resemble later epiblast stages, are biased toward primitive endoderm differentiation, or have unknown identity ([@bib6], [@bib25], [@bib44]). It has been reported that minimal ERK activity is required for self-renewal and differentiation ([@bib10]). We speculate that not all Nanog low cells are similarly dependent on ERK signaling. The state of some cells might be closer to epiblast-derived stem cells, which self-renew in the presence of fibroblast growth factor (FGF)/ERK signaling and have severe viability defects in 2i ([@bib19]). ERK activity is also crucial for the differentiation into primitive endoderm (prEn; [@bib20]). It is thus plausible that the prEn-primed or committed Nanog low cells also have a greater dependency on ERK activity and hence reduced viability in 2i. In addition, we found some cells that were even refractory to inducing Nanog stably or at all, indicating that atypical ESCs in SerumLIF exist in a continuum of states.

It is likely that the departure from the naive state correlates with the long-term absence of Nanog expression ([@bib17]). We speculate that cells with only a recent decrease in Nanog expression are typically still in or close to a bona fide ESC state, and thus can survive in 2i and eventually stabilize or restore naive pluripotency. Thus, a short-term decrease in Nanog levels does not commit cells toward differentiation, as similarly a short-term increase in Nanog expression does not shield them from death in 2i. We suggest that the induction of one or few regulatory factors in non-bona fide ESCs is more readily accomplished than reprogramming of the cell fate, which likely requires a substantial change of the entire gene regulatory network. We propose that resetting or maintaining naive pluripotency depends on both a potent inducer such as 2i, but also a responsive and compatible initial cell state. We conclude that NANOG is not an essential, but an important factor in mediating the self-renewal promoting effect of 2i. Our data also confirm that heterogeneous expression of Nanog exists and is functionally relevant, a concept that had been questioned ([@bib15]).

Surprisingly, we saw an initial 2i-independent NANOG drop in Nanog high cells with the Nanog^KATUSHKA^ reporter that measures NANOG protein levels but not with the Nanog:GFP reporter, which measures *Nanog* promoter activity of a transgene. While cell-line-specific genetic and epigenetic differences cannot be excluded and additional *cis*-regulatory elements absent in the Nanog:GFP reporter might play a role, a plausible explanation is that simultaneous post-transcriptional mechanisms overshadow the transcription-based 2i-mediated Nanog induction during the first hours after 2i addition. As this effect also occurred in SerumLIF, we do not think it depicts a reorganization of the pluripotency network in 2i ([@bib18]).

The fact that a selective effect of 2i treatment indeed exists in ESCs could question previous studies\' conclusions on Nanog induction by 2i treatment. However, since we showed that at the single-cell level 2i treatment also induces Nanog expression, the Nanog-inductive effect of 2i postulated in previous studies was potentially overestimated but likely correct.

For the reprogramming of human ESCs toward a naive state, the use of 2i seems crucial but not sufficient. Interestingly, short-term expression of NANOG and KLF2 allows one to overcome this barrier ([@bib40], [@bib42]). This indicates that those two TFs can restructure the cells\' gene regulatory network in such a way that 2i can have the desired effects.

Two studies recently showed that 2i, especially MEK inhibition, not only promotes pluripotency but also severely diminishes the developmental potential of ESCs by inducing irreversible genetic and epigenetic aberrations ([@bib12], [@bib46]). Those two effects are especially dramatic upon long-term culture and in female cells, respectively. Replacing the MEK inhibitor by an Src inhibitor, or reducing its concentration, could overcome these problems while preserving many of the desired effects of 2i. This highlights how important it is to fully understand the complex effects of 2i on pluripotent cells. A line of evidence suggests that the precise control of MEK/ERK signaling will be critical in generating stable and naive pluripotent cells from a variety of species including humans, independent of their sex ([@bib10], [@bib11], [@bib12], [@bib35], [@bib46]).

2i or FGF/MEK inhibition alone also strongly increases the number of Nanog-positive epiblast cells during preimplantation development of mouse embryos in endoderm marker-expressing hypoblast cells. Most likely in this process, FGF/MEK inhibition induces Nanog and instructs lineage choice without any selective effects ([@bib29], [@bib47]). As cells from early blastocyst stages are very plastic, they might be easily instructed by 2i, in contrast to a subset of Nanog^low^ ESCs. The viability of ESCs cultured in SerumLIF after injection into preimplantation embryos depends on the expression of the pluripotency marker Zfp42 (previously known as Rex1; [@bib3]). The low viability of Nanog low cells after cell splitting seems consistent with these observations, but it is also possible that the preimplantation embryo represents a selective environment against cells with low pluripotency gene expression, similarly to 2i *in vitro*.

Experimental Procedures {#sec4}
=======================

ESC Culture {#sec4.1}
-----------

Mouse ESC lines NG4 ([@bib34]) and R1 containing a Nanog^KATUSHKA^ allele report Nanog promoter activity by GFP, or endogenous NANOG protein levels by a Nanog-fluorescent protein (KATUSHKA) fusion, respectively. The ESC line TβC44Cre6 was used as Nanog^−/−^ cells ([@bib9]). All lines were routinely passaged every 2 days in Serum + LIF containing medium on gelatin or before experiments on E-cadherin-coated cell-culture plates. For SerumLIF+2i and N2B27 + LIF+2i medium, MEK inhibitor PD0325901 and GSK3 inhibitor CHIR99021 were added to SerumLIF or N2B27 + LIF at final concentrations of 1 μM and 3 μM, respectively.

Quantitative Time-Lapse Imaging {#sec4.2}
-------------------------------

ESCs were cultured in SerumLIF, SerumLIF+2i, or N2B27 + LIF+2i medium on E-cadherin-coated culture slides and imaged at 30-min intervals for 2 days in both bright-field and fluorescent light channels in a 5% CO~2~ and 5% O~2~ mixed gas atmosphere at 37°C under a Zeiss Axio Observer Z1 microscope.

One random branch per tree was manually tracked and cell death events were determined using the software tTt ([@bib22]). Fluorescent image illumination was normalized, and Nanog intensities and cell areas of single cells were quantified as described by [@bib17].

Data Processing and Statistics {#sec4.3}
------------------------------

Nanog intensity values were pooled for most analyses after normalization of replicate experiments ([Figure S1](#mmc1){ref-type="supplementary-material"}E). The Cochran-Mantel-Haenszel chi-squared test was used to compare cell death rates in replicate experiments ([Figures 2](#fig2){ref-type="fig"}A, [S2](#mmc1){ref-type="supplementary-material"}B, and S2C) and the Wilcoxon rank-sum test was used to compare Nanog fold changes ([Figures 3](#fig3){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}A). See also [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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Document S1. Supplemental Experimental Procedures and Figures S1--S4Video S1. Cell Death and Ceased Proliferation in a Nanog:GFP Colony after 2i TreatmentVideo S2. Upregulation of Nanog:GFP after 2i TreatmentVideo S3. Upregulation of Nanog^KATUSHKA^ after 2i TreatmentVideo S4. Cell Death, Ceased Proliferation, and Nanog Upregulation of Individual Cells in a Nanog:GFP Colony after 2i TreatmentDocument S2. Article plus Supplemental Information
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